Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.
Richard B WarrenIain B McInnesPeter NashJean-Marie GrouinNikos LyrisDamon WillemsVanessa TaiebJason EellsPhillip J MeasePublished in: Rheumatology and therapy (2024)
NCT03895203, NCT03896581, NCT04009499, NCT03158285, NCT03796858.
Keyphrases